Electrospray ionisation (revision 8)
Old revision·15:23, 14 Dec 2024·Areapercent_Ayo
| Electrospray ionisation | |
|---|---|
| Abbreviation | ESI |
| Produces | Multiply charged ions from solution |
| Nature | Soft; molecule survives intact |
| Compatible with | Liquid chromatography |
| Analytical method infobox · conventions | |
Electrospray ionisation transfers molecules from solution into the gas phase as ions. A solution is sprayed from a capillary held at high potential, producing charged droplets whose solvent evaporates until ions are released.[1]
It is a soft technique — the molecule survives largely intact — and it produces multiply charged ions from peptides and proteins, so a large molecule appears at a mass-to-charge ratio within the range of ordinary analysers. A single peptide therefore produces a series of peaks at successive charge states, deconvolved by software into one neutral mass.[2]
Because it works from flowing solution, it couples directly to chromatography, which is what makes LC-MS possible.[1]
Mechanism
[edit]The applied potential draws the liquid into a cone from whose tip a fine spray of charged droplets emerges. Solvent evaporates, the droplets shrink until charge repulsion exceeds surface tension, and they divide. Ions are ultimately released either by field-driven ejection from very small droplets or by complete evaporation of the solvent around them.[1]
The charge states observed depend on the number of ionisable sites and on solution conditions. Acidic mobile phases favour protonation and positive-mode operation, which is why peptide LC-MS is usually run in positive mode with an acidic modifier.[2]
Ion suppression is the characteristic difficulty: co-eluting species compete for charge, so a compound's signal depends on what else is eluting at the same time. This is why the technique is not quantitative without calibration.[3]
References
- ^ a b c Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. "Electrospray ionization for mass spectrometry of large biomolecules." Science 246(4926):64–71 (1989). PMID 2675315.
- ^ a b Aebersold R, Mann M. "Mass spectrometry-based proteomics." Nature 422(6928):198–207 (2003). PMID 12634793.
- ^ United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.